Sequencing Electrophoresis Systems Market

By Type;

Glass Sequencing Electrophoresis Systems and Plastic Sequencing Electrophoresis Systems

By Application;

Pharmaceutical, Microbiology, Chemical, Bio-Chemical, Nanotechnology and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn470371574 Published Date: September, 2025 Updated Date: October, 2025

Sequencing Electrophoresis Systems Market Overview

Sequencing Electrophoresis Systems Market (USD Million)

Sequencing Electrophoresis Systems Market was valued at USD 6,787.05 million in the year 2024. The size of this market is expected to increase to USD 9,671.68 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.9%.


Sequencing Electrophoresis Systems Market

*Market size in USD million

CAGR 5.9 %


Study Period2025 - 2031
Base Year2024
CAGR (%)5.9 %
Market Size (2024)USD 6,787.05 Million
Market Size (2031)USD 9,671.68 Million
Market ConcentrationMedium
Report Pages354
6,787.05
2024
9,671.68
2031

Major Players

  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • QIAGEN N.V.
  • Beckman Coulter, Inc. (a subsidiary of Danaher Corporation)
  • PerkinElmer, Inc.
  • Merck KGaA
  • Promega Corporation
  • Lonza Group Ltd.
  • Harvard Bioscience, Inc.

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Sequencing Electrophoresis Systems Market

Fragmented - Highly competitive market without dominant players


The Sequencing Electrophoresis Systems Market is experiencing significant growth as advancements in genomic research and biotechnology drive demand for precise and efficient DNA sequencing methods. Approximately 55% of laboratories and research institutions are adopting electrophoresis systems to enhance their DNA sequencing capabilities, making these systems indispensable in modern genetic analysis and molecular biology.

Key Drivers of Market Growth
The growing demand for personalized medicine and genetic diagnostics is one of the main drivers behind the adoption of sequencing electrophoresis systems. Around 60% of new clinical and research applications require DNA sequencing for detecting genetic disorders and tailoring treatments. As the demand for precision medicine increases, the need for high-quality sequencing technologies also rises, propelling market growth.

Technological Advancements
Innovative developments in electrophoresis technology are boosting the efficiency and accuracy of DNA sequencing. Around 50% of recent advancements in sequencing systems are focused on improving resolution, speed, and throughput. These innovations enable researchers to perform faster and more accurate sequencing, reducing the time and costs involved in genetic analysis and enhancing research outcomes.

Increasing Adoption in Research and Diagnostics
Electrophoresis systems are becoming integral in both genetic research and clinical diagnostics, with around 70% of research institutes and hospitals now utilizing these systems for analyzing DNA and RNA samples. As precision in genetic testing becomes more critical, the market for sequencing electrophoresis systems continues to expand in response to the growing need for advanced diagnostic solutions.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Sequencing Electrophoresis Systems
    2. Market Snapshot, By Product Type
    3. Market Snapshot, By Application
    4. Market Snapshot, By End-User
    5. Market Snapshot, By Region
  4. Sequencing Electrophoresis Systems Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Technological advancements
        2. Sequencing technologies driving market growth
      2. Restraints
        1. High costs associated with equipment
        2. Maintenance limiting adoption
      3. Opportunities
        1. Increasing demand for personalized medicine
        2. Genetic research
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Sequencing Electrophoresis Systems Market, By Sequencing Electrophoresis Systems, 2021 - 2031 (USD Million)
      1. Glass Sequencing Electrophoresis Systems
      2. Plastic Sequencing Electrophoresis Systems
    2. Sequencing Electrophoresis Systems Market, By Product Type, 2021 - 2031 (USD Million)

      1. Capillary Electrophoresis Systems

      2. Gel Electrophoresis Systems

    3. Sequencing Electrophoresis Systems Market, By Application, 2021 - 2031 (USD Million)
      1. Microbiology
      2. Chemical
      3. Bio-chemical
      4. Nanotechnology
      5. Pharmaceutical
      6. Other Application Areas
    4. Sequencing Electrophoresis Systems Market, By End-User, 2021 - 2031 (USD Million)

      1. Hospitals

      2. Diagnostic Laboratories

      3. Research Centers

      4. Others

    5. Sequencing Electrophoresis Systems Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Thermo Fisher Scientific
      2. Bio-Rad Laboratories
      3. Agilent Technologies
      4. Illumina, Inc.
      5. Merck KGaA (MilliporeSigma)
      6. PerkinElmer, Inc.
      7. Qiagen N.V.
      8. Beckman Coulter, Inc.
      9. GE Healthcare Life Sciences (Cytiva)
      10. Shimadzu Corporation
      11. Hitachi High-Tech Corporation
      12. Advanced Analytical Technologies, Inc.
      13. Lonza Group AG
      14. Oxford Nanopore Technologies
      15. Eppendorf AG
  7. Analyst Views
  8. Future Outlook of the Market